These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 21554152)

  • 21. Development and in vitro evaluation of diltiazem hydrochloride transdermal patches based on povidone-ethylcellulose matrices.
    Gupta R; Mukherjee B
    Drug Dev Ind Pharm; 2003 Jan; 29(1):1-7. PubMed ID: 12602487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fabrication and evaluation of polymeric films for transdermal delivery of pinacidil.
    Aqil M; Ali A; Sultana Y; Najmi AK
    Pharmazie; 2004 Aug; 59(8):631-5. PubMed ID: 15378854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Double-layer weekly sustained release transdermal patch containing gestodene and ethinylestradiol.
    Gao Y; Liang J; Liu J; Xiao Y
    Int J Pharm; 2009 Jul; 377(1-2):128-34. PubMed ID: 19463930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of the Component Excipients on the Quality and Functionality of a Transdermal Film Formulation.
    Saoji SD; Atram SC; Dhore PW; Deole PS; Raut NA; Dave VS
    AAPS PharmSciTech; 2015 Dec; 16(6):1344-56. PubMed ID: 25922089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of DC/mDC iontophoresis and terpenes on transdermal permeation of methotrexate: in vitro study.
    Prasad R; Koul V; Anand S; Khar RK
    Int J Pharm; 2007 Mar; 333(1-2):70-8. PubMed ID: 17116378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formulation, in vitro, and in vivo evaluation of matrix-type transdermal patches containing olanzapine.
    Aggarwal G; Dhawan S; Harikumar SL
    Pharm Dev Technol; 2013; 18(4):916-25. PubMed ID: 21913873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes.
    Dubey V; Mishra D; Dutta T; Nahar M; Saraf DK; Jain NK
    J Control Release; 2007 Nov; 123(2):148-54. PubMed ID: 17884226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and development of insulin emulgel formulation for transdermal drug delivery and its evaluation.
    Akram M; Naqvi SB; Khan A
    Pak J Pharm Sci; 2013 Mar; 26(2):323-32. PubMed ID: 23455203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A drug-in-adhesive transdermal patch for S-amlodipine free base: in vitro and in vivo characterization.
    Sun Y; Fang L; Zhu M; Li W; Meng P; Li L; He Z
    Int J Pharm; 2009 Dec; 382(1-2):165-71. PubMed ID: 19716871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Controlled transdermal delivery of model drug compounds by MEMS microneedle array.
    Xie Y; Xu B; Gao Y
    Nanomedicine; 2005 Jun; 1(2):184-90. PubMed ID: 17292077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of Statistical Tooling Techniques for Designing of Carvedilol Nanolipid Transferosomes and its Dermatopharmacokinetic and Pharmacodynamic Studies.
    Selvaraj BR; Sridhar SK; Kesavan BR; Palagati S
    Pharm Nanotechnol; 2020; 8(6):452-470. PubMed ID: 32988361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fabrication and characterization of matrix type transdermal patches loaded with tizanidine hydrochloride: potential sustained release delivery system.
    Shahid N; Siddique MI; Razzaq Z; Katas H; Waqas MK; Rahman KU
    Drug Dev Ind Pharm; 2018 Dec; 44(12):2061-2070. PubMed ID: 30081679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Silicone adhesive, a better matrix for tolterodine patches-a research based on in vitro/in vivo studies.
    Liu J; Wang Z; Liu C; Xi H; Li C; Chen Y; Sun L; Mu L; Fang L
    Drug Dev Ind Pharm; 2012 Aug; 38(8):1008-14. PubMed ID: 22126709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and Evaluation of Transdermal Patches of Timolol Maleate.
    Panchayya Hiremath SS; Reddy JJ; Jamakandi VG
    Curr Drug Deliv; 2018; 15(5):658-663. PubMed ID: 28969565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formulation study of a patch containing propranolol by design of experiments.
    Cilurzo F; Minghetti P; Gennari CG; Casiraghi A; Selmin F; Montanari L
    Drug Dev Ind Pharm; 2014 Jan; 40(1):17-22. PubMed ID: 23301830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a Prolonged-Release Pramipexole Transdermal Patch: In Vitro and In Vivo Evaluation.
    Pu T; Li X; Sun Y; Ding X; Pan Y; Wang Q
    AAPS PharmSciTech; 2017 Apr; 18(3):738-748. PubMed ID: 27245330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on transdermal delivery enhancement of zidovudine.
    Takmaz EA; Inal O; Baykara T
    AAPS PharmSciTech; 2009; 10(1):88-97. PubMed ID: 19148760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and evaluation of carvedilol-loaded transdermal drug delivery system: In-vitro and in-vivo characterization study.
    Kshirsagar SJ; Bhalekar MR; Mohapatra SK
    Drug Dev Ind Pharm; 2012 Dec; 38(12):1530-7. PubMed ID: 22356303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro and in vivo characterization of novel biomaterial for transdermal application.
    Mundada AS; Avari JG
    Curr Drug Deliv; 2011 Sep; 8(5):517-25. PubMed ID: 21696352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel transdermal patch incorporating meloxicam: in vitro and in vivo characterization.
    Ah YC; Choi JK; Choi YK; Ki HM; Bae JH
    Int J Pharm; 2010 Jan; 385(1-2):12-9. PubMed ID: 19833177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.